MBX Biosciences - Latest News and Information
MBX
MBX Biosciences is a clinical-stage biopharmaceutical company focused on discovering and developing precision peptide therapies for endocrine and metabolic disorders. The company advances a pipeline of novel peptide candidates targeting clinically validated endpoints with potential to address large unmet medical needs. MBX emphasizes transforming patient outcomes in endocrine and metabolic diseases through science-driven development and regulatory-aligned programs. It operates with an emphasis on focused, specialty programs and is based in the United States.
No recent news for this company.
